What is the intent behind U0002? Is it true that it is reportable for in-house developed tests?
HCPCS U0002 allows laboratories and healthcare facilities to bill CMS for validated, in-house developed COVID-19 tests. By code definition, the test must detect multiple types or subtypes; it should not be used for CDC.
|U0002||2019-nCoV Coronavirus, SARSCoV- 2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC|
This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.